Abstract
The aim of the present study was to design a controlled porosity osmotic pump tablet of atenolol. The controlled porosity osmotic pump tablet contains pore-forming water-soluble additives in the coating membrane, which after coming in contact with water, dissolve, resulting in an in situ formation of a microporous structure. The dosage regimen of atenolol is 25-mg tablet 2 to 3 times a day. The plasma half-life ranges from ~6 to 7 hours. Hence, Atenolol was chosen as a model drug with an aim to develop a controlled release system for a period of 12 hours. The effect of different formulation variables, namely, ratio of drug to osmogent and level of pore former on the in vitro release was studied by applying a full 3 2 factorial design. Cellulose acetate (CA) was used as a semipermeable membrane. It was found that drug release was directly related to the amount of osmogent and level of pore former. In-vivo study was performed in rabbits and various parameters C max , t max , AUC, AUMC and MRT were calculated and compared with that of marketed conventional tablet. The optimized formulation was subjected to stability studies as per International Conference on Harmonization (ICH) guidelines and formulation was stable after a 3 month study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
